Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
The "mechanistic target of rapamycin" (mTOR) is a central controller of growth, proliferation and/or motility of various cell-types ranging from adipocytes to immune cells, thereby linking metabolism and immunity. mTOR signaling is overactivated in obesity, promoting inflammation and insul...
Guardado en:
Autores principales: | Kassem Makki, Solenne Taront, Olivier Molendi-Coste, Emmanuel Bouchaert, Bernadette Neve, Elodie Eury, Stéphane Lobbens, Myriam Labalette, Hélène Duez, Bart Staels, David Dombrowicz, Philippe Froguel, Isabelle Wolowczuk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d9f98ed9519749d696812e9679e5562a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Cheng-Hung Lee, et al.
Publicado: (2017) -
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
por: Amine Meliani, et al.
Publicado: (2018) -
Auxin and Target of Rapamycin Spatiotemporally Regulate Root Organogenesis
por: Xiulan Xie, et al.
Publicado: (2021) -
SIRT1 negatively regulates the mammalian target of rapamycin.
por: Hiyaa Singhee Ghosh, et al.
Publicado: (2010) -
Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse model
por: Ching-Tai Huang, et al.
Publicado: (2017)